This is where many people are searching for the newer peptide still in clinical trials -Retatrutide
3.5% on semaglutide
Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats
Results Clinical evidence shows that taking semaglutide typically results in sustained, clinically relevant body weight reduction
Farmaci incretinici di nuova generazione: opportunit, limiti e implicazioni cliniche per lobesit Riccardo Dalle Grave Introduzione Negli ultimi quindici anni i farmaci incretinici, in particolare gli agonisti del recettore del GLP1 e le pi recenti molecole duali e triple, hanno profondamente modificato il trattamento del diabete di tipo 2 e, pi recentemente, dellobesit
Electronic databases including PubMed, Embase, and Web of Science were searched from inception until August 2025 using keywords such as GLP-1 receptor agonist, diabetic retinopathy, glaucoma, age-related macular degeneration, ocular disease, and neuroprotection. The search focused on identifying preclinical studies, large-scale retrospective cohort studies, and post-hoc analyses of major clinical trials that evaluated the utility and potential mechanisms of GLP-1RAs in ophthalmic diseases